NSEPress Release30 Sept 2026 · 30 Sept 2026, 05:57 pm

Press Release

Avio Smart Market Stack Limited · ASMS

✦ AI Summary▲ PositiveExpansion

Avio Smart Market Stack Limited has partnered with Huwel Lifesciences to expand access to compact RT-PCR testing across India, establishing a dedicated sales and distribution infrastructure.

Analysis Scores

Earnings Impact6/10
Growth Catalyst8/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact9/10
Market Sentiment8/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Avio Smart Market Stack Limited has informed the Exchange regarding a press release dated September 30, 2026, titled "ASMS and Huwel Lifesciences Join Hands to Expand Access to Compact RT-PCR Testing Across India".

Attachments (1)

📄

BARTRONICS1_30092026175703_Press_release_dated_30september.pdf

pdf

Download →
View document text
Date: 30.09.2026 To, To, BSE Limited, National Stock exchange of India Limited, Listing Department, P.J. Towers, Dalal Exchange Plaza, C-1, Block G, Street, Mumbai – 400 001 Bandra Kurla Complex, Bandra (E) Scrip Code: 532694 Mumbai – 400 051 Symbol: ASMS Dear Sir/Madam, Sub: Intimation regarding Press Release under Regulation 30 of SEBI (LODR) Regulations, 2015 Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed a copy of the Press Release being issued by the Company today titled: “ASMS and Huwel Lifesciences Join Hands to Expand Access to Compact RT-PCR Testing Across India”. A copy of the said Press Release is enclosed herewith as Annexure – I. You are requested to kindly take the above information on record. Yours faithfully, For Avio Smart Market Stack Limited (Formerly Known as Bartronics India Limited) Diksha Omer Company Secretary ANNEXURE-I ASMS and Huwel Lifesciences Join Hands to Expand Access to Compact RT-PCR Testing Across India National, 30th September 2026: Avio Smart Market Stack Limited (ASMS), (formerly known as Bartronics India Limited), and Huwel Lifesciences are strengthening their collaboration to build a nationwide commercialisation platform for Cubo, Huwel’s ultra-compact RT-PCR system. The initiative aims to expand access to molecular diagnostics across India’s private healthcare sector, including hospitals, diagnostic centres, research institutions and smaller healthcare facilities. As part of the collaboration, the two companies plan to establish a dedicated sales and distribution infrastructure, including the recruitment of senior sales leadership, formation of specialised sales teams and development of strategic channel partnerships. The initiative will initially focus on Cubo while creating opportunities to commercialise Huwel’s broader molecular diagnostics portfolio. Commenting on the collaboration, N Vidhya Sagar Reddy, Managing Director, ASMS, said, “The next phase of our collaboration with Huwel is focused on building the commercial infrastructure needed to take advanced molecular diagnostic technologies to a much wider customer base. Cubo’s compact format creates an opportunity to bring RT-PCR capabilities closer to hospitals, laboratories and other healthcare providers, including those outside the traditional centralised laboratory ecosystem. Our focus will be on building the sales leadership, distribution network and market coverage required to support its adoption at scale across India.” Cubo is designed to enable RT-PCR testing beyond conventional centralised laboratory environments. Its ultra-compact design allows molecular diagnostic capabilities to be considered for smaller and more decentralised healthcare settings, potentially reducing dependence on large centralised facilities. This is particularly relevant to India’s healthcare landscape, which spans metropolitan centres as well as a large and geographically distributed network of Tier-II and Tier-III cities, hospitals and diagnostic facilities. The commercialisation strategy will focus on private hospitals, diagnostic chains, independent laboratories, medical colleges, research institutions and other healthcare establishments. The proposed sales organisation will work across direct sales and channel partnerships, supported by product demonstrations, installation support and ongoing customer engagement. Beyond instrument deployment, ASMS and Huwel intend to develop an ecosystem around the platform, comprising compatible molecular assays and consumables that can support recurring testing requirements. Huwel’s capabilities across molecular diagnostic applications could enable Cubo installations to serve multiple testing needs rather than being limited to a single application. The collaboration marks the next phase of the relationship between ASMS and Huwel, with the focus now expanding from product and institutional opportunities towards building a broader commercial engine for Huwel’s molecular diagnostics portfolio. For ASMS, the initiative represents an opportunity to build its presence in healthcare and diagnostics through indigenous technologies, while Huwel gains additional commercial reach and execution capabilities to support the wider adoption of its products. Through the planned sales leadership, distribution partnerships and nationwide market coverage, the companies aim to create a scalable commercial platform that can take compact molecular diagnostic capabilities to a broader universe of healthcare providers across India. About Avio Smart Market Stack Limited Avio Smart Market Stack Limited (ASMS) is a diversified platform company focused on building scalable businesses across Financial Inclusion & Digital Services, Agri Supply Chain & Technologies, and Diagnostics & Healthcare. Through its Financial Inclusion division, the Company has established a strong presence across rural India, creating a trusted distribution network. Building on this foundation, ASMS is developing a technology-enabled agri ecosystem while leveraging its existing reach. The Company has also entered into a strategic partnership with a cutting-edge molecular diagnostics company to diversify into the high-growth healthcare and diagnostics sector.